Protecting America’s Medicine Cabinet

Mar 10, 2022 | Events

Dr. Elisabeth Reynolds, Special Assistant to the President for Manufacturing and Economic Development, National Economic Council, The White House; Dr. Karen Summar, Former Healthcare Director to Sen. Chuck Grassley (R-IA) and Sen. Blackburn (R-TN); and Phlow’s CEO, Eric Edwards, MD, PhD spoke in the CQ Roll Call Event: Protecting America’s Medicine Cabinet on March 10, 2022.

This event highlighted the need for continued bicameral and bipartisan collaboration around medical shortages and the importance of enhancing domestic manufacturing and providing diversity in the supply chain to ensure that essential medicines are available for all Americans without disruption.

Essential medicines are the priority medications that are critical to have available at all times to sustain the health of the American population. Leveraging state-of-the-art green chemistry, continuous flow technology, and other advanced manufacturing processes can improve the development and manufacturing of APIs and finished pharmaceutical products critical to U.S. healthcare while also reducing the nation’s reliance on imports from foreign nations.

Protecting America’s Medicine Cabinet, a virtual event, discussed critical topics surrounding the essential medicine supply chain, including:

  • Key Components to Ensure a U.S. Based Supply Chain
  • Continuous Manufacturing in the U.S.
  • The Administration’s 100 Day Supply Chain Review: What are the solutions to America’s supply chain vulnerabilities?
  • America’s Role in Preventing Essential Medicine Shortages


See the Presentation

Presentation Highlights

White House Supply Chain Report

Continuous Manufacturing — R&D

Domestic Manufacturing

Essential Medicine List

Public Policy & Public Private Partnerships